CLINICAL_TRIALS
ClinicalTrials.gov record update
Evaluate Immuno and Safety of GSKBiologicals' HibMenCYTT vs Licensed Hib Conjugate Vaccine, Each Coadministered With Pediarix® and Prevnar®, in Healthy Infants. An Exploratory Control Group Will Receive Licensed Menomune® at 3 to 5 Years
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00129129
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:49.510081+00:00
- Published At
- 2013-12-30T00:00:00+00:00
- Record Updated At
- 2018-08-24
- Results Posted At
- 2013-12-30
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Haemophilus Influenzae Type b", "Neisseria Meningitidis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-08-24"- protocolSection.identificationModule.nctId
"NCT00129129"- protocolSection.identificationModule.officialTitle
"Evaluate Immuno and Safety of GSKBiologicals\u0027 HibMenCYTT vs Licensed Hib Conjugate Vaccine, Each Coadministered With Pediarix\u00ae and Prevnar\u00ae, in Healthy Infants. An Exploratory Control Group Will Receive Licensed Menomune\u00ae at 3 to 5 Years"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-12-30"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.